First-lineEltroxin

Levothyroxine

Synthetic thyroid hormone (T4)

Hypothyroidism in pregnancy — increase dose early, monitor TSH q4–6 wks.

Oral

First-line for

  • Pre-existing hypothyroidism
  • Subclinical hypothyroidism with TPO antibodies

Mechanism

Replaces endogenous T4 → converted to active T3 → nuclear receptor signalling → metabolic regulation.

“+30% by +6”

  • Increase dose ~25–30% as soon as pregnancy confirmed
  • Recheck TSH at 6 weeks (and q4–6 weekly)
  • Target TSH <2.5 mIU/L T1; <3 mIU/L T2/T3
  • Return to pre-pregnancy dose immediately postpartum

Dosing

Pre-existing
↑ existing dose by 25–30% on positive test
New diagnosis
1.6–2.0 mcg/kg/day

Contraindications

  • AbsoluteUntreated thyrotoxicosis, adrenal insufficiency

Side effects

  • Palpitations, tremor (overdose)
  • Insomnia, weight loss (overdose)
  • Reduced bone density (chronic over-replacement)

Fetal & maternal notes

  • Crosses placenta minimally — but maternal hypothyroidism causes ↓ fetal IQ.
  • Safe in breastfeeding.

Key interactions

  • Iron, calcium, PPIs

    Caution

    ↓ absorption — separate by ≥4 h

  • Oestrogen (HRT)

    Caution

    ↑ TBG → may need ↑ dose

Clinical pearls

  • 💡 Take fasting, 30–60 min before breakfast.
  • 💡 Iodine supplementation in pregnancy 150 mcg/day.

Content last reviewed: REPLACE_ME (e.g. 2026-07)

Spotted something out of date? See our disclaimer or use Report an Error above.

For educational use only

Not medical advice. Verify dosing against the BNF and your local trust guidelines before prescribing.